tamibarotene has been researched along with decitabine in 1 studies
| Studies (tamibarotene) | Trials (tamibarotene) | Recent Studies (post-2010) (tamibarotene) | Studies (decitabine) | Trials (decitabine) | Recent Studies (post-2010) (decitabine) |
|---|---|---|---|---|---|
| 198 | 10 | 105 | 3,804 | 205 | 2,177 |
| Protein | Taxonomy | tamibarotene (IC50) | decitabine (IC50) |
|---|---|---|---|
| DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekimoto, H; Ishigami-Yuasa, M; Kagechika, H | 1 |
1 other study(ies) available for tamibarotene and decitabine
| Article | Year |
|---|---|
Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer.
Topics: Antineoplastic Agents; Benzoates; Cell Line, Tumor; Decitabine; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Male; Prostatic Neoplasms; Pyridines; Receptors, Retinoic Acid; Sulfonamides; Tetrahydronaphthalenes; Vorinostat | 2019 |